These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 1509926

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A controlled study of alprazolam and propranolol in panic-disordered and agoraphobic outpatients.
    Ravaris CL, Friedman MJ, Hauri PJ, McHugo GJ.
    J Clin Psychopharmacol; 1991 Dec; 11(6):344-50. PubMed ID: 1770152
    [Abstract] [Full Text] [Related]

  • 3. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia.
    Bakish D, Hooper CL, Filteau MJ, Charbonneau Y, Fraser G, West DL, Thibaudeau C, Raine D.
    Psychopharmacol Bull; 1996 Dec; 32(1):135-41. PubMed ID: 8927663
    [Abstract] [Full Text] [Related]

  • 4. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.
    Pols H, Verburg K, Hauzer R, Meijer J, Griez E.
    Biol Psychiatry; 1996 Nov 01; 40(9):913-7. PubMed ID: 8896779
    [Abstract] [Full Text] [Related]

  • 5. Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder?
    Maier W, Roth SM, Argyle N, Buller R, Lavori P, Brandon S, Benkert O.
    Eur Arch Psychiatry Clin Neurosci; 1991 Nov 01; 241(3):151-8. PubMed ID: 1790160
    [Abstract] [Full Text] [Related]

  • 6. [Comparison of the effect of alprazolam, imipramine and placebo in the treatment of panic disorders in Cali, Colombia].
    León CA, De Arango MV, Arevalo W, Calvo A, Montoya A, León A.
    Acta Psiquiatr Psicol Am Lat; 1990 Nov 01; 36(1-2):59-72. PubMed ID: 2073024
    [Abstract] [Full Text] [Related]

  • 7. A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder.
    Lydiard RB, Lesser IM, Ballenger JC, Rubin RT, Laraia M, DuPont R.
    J Clin Psychopharmacol; 1992 Apr 01; 12(2):96-103. PubMed ID: 1573046
    [Abstract] [Full Text] [Related]

  • 8. The structure of phobias in panic disorder.
    Argyle N, Solyom C, Solyom L.
    Br J Psychiatry; 1991 Sep 01; 159():378-82. PubMed ID: 1958949
    [Abstract] [Full Text] [Related]

  • 9. Personality dimensions in panic disorder before and after effective treatment.
    Starcevic V, Uhlenhuth EH.
    Anxiety; 1996 Sep 01; 2(2):95-8. PubMed ID: 9160608
    [No Abstract] [Full Text] [Related]

  • 10. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
    Charney DS, Woods SW, Goodman WK, Rifkin B, Kinch M, Aiken B, Quadrino LM, Heninger GR.
    J Clin Psychiatry; 1986 Dec 01; 47(12):580-6. PubMed ID: 3536889
    [Abstract] [Full Text] [Related]

  • 11. A meta-analysis of treatments for panic disorder with agoraphobia: imipramine, alprazolam, and in vivo exposure.
    Cox BJ, Endler NS, Lee PS, Swinson RP.
    J Behav Ther Exp Psychiatry; 1992 Sep 01; 23(3):175-82. PubMed ID: 1487535
    [Abstract] [Full Text] [Related]

  • 12. Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks.
    Munjack DJ, Crocker B, Cabe D, Brown R, Usigli R, Zulueta A, McManus M, McDowell D, Palmer R, Leonard M.
    J Clin Psychopharmacol; 1989 Feb 01; 9(1):22-7. PubMed ID: 2651490
    [Abstract] [Full Text] [Related]

  • 13. The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder.
    Moylan S, Staples J, Ward SA, Rogerson J, Stein DJ, Berk M.
    J Clin Psychopharmacol; 2011 Oct 01; 31(5):647-52. PubMed ID: 21869686
    [Abstract] [Full Text] [Related]

  • 14. [Patients with panic disorder: a 5-year follow-up study].
    León CA, Arévalo W, Gaviria LF, Leon A.
    Acta Psiquiatr Psicol Am Lat; 1992 Dec 01; 38(4):279-88. PubMed ID: 1341123
    [Abstract] [Full Text] [Related]

  • 15. Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia.
    Lesser IM, Lydiard RB, Antal E, Rubin RT, Ballenger JC, DuPont R.
    Am J Psychiatry; 1992 Nov 01; 149(11):1556-62. PubMed ID: 1415824
    [Abstract] [Full Text] [Related]

  • 16. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.
    Rizley R, Kahn RJ, McNair DM, Frankenthaler LM.
    Psychopharmacol Bull; 1986 Nov 01; 22(1):167-72. PubMed ID: 2873609
    [No Abstract] [Full Text] [Related]

  • 17. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
    Pyke RE, Greenberg HS.
    J Clin Psychopharmacol; 1989 Feb 01; 9(1):15-21. PubMed ID: 2651489
    [Abstract] [Full Text] [Related]

  • 18. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis.
    Boyer W.
    Int Clin Psychopharmacol; 1995 Mar 01; 10(1):45-9. PubMed ID: 7622804
    [Abstract] [Full Text] [Related]

  • 19. Controlled trial of alprazolam supplementation during imipramine treatment of panic disorder.
    Woods SW, Nagy LM, Koleszar AS, Krystal JH, Heninger GR, Charney DS.
    J Clin Psychopharmacol; 1992 Feb 01; 12(1):32-8. PubMed ID: 1552038
    [Abstract] [Full Text] [Related]

  • 20. Maintenance drug therapy of panic disorder.
    Curtis GC, Massana J, Udina C, Ayuso JL, Cassano GB, Perugi G.
    J Psychiatr Res; 1993 Feb 01; 27 Suppl 1():127-42. PubMed ID: 8145175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.